US Patent 9815791 Alkylpyrazolyl guanidine F
Patent 9815791 was granted and assigned to Lycera on November, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+257 characters)
Article
Patent abstract
The invention provides pyrazolyl guanidine compounds that inhibit F1Fo-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Chad A. VanHuis0
Donald J. Skalitzky0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09815791 Alkylpyrazolyl guanidine F US Patent 9815791 Alkylpyrazolyl guanidine F
Infobox
Patent Number
09815791
Patent Number
9815791
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09815791 Alkylpyrazolyl guanidine F
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09815791
Date of patent
November 14, 2017
Patent application number
15101129
Date Filed
December 10, 2014
Patent primary examiner
Find more entities like US Patent 9815791 Alkylpyrazolyl guanidine F
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.